{
  "@context": "http://id.who.int/icd/contexts/contextForLinearizationEntity.json",
  "@id": "http://id.who.int/icd/release/11/2024-01/mms/976309888",
  "parent": [
    "http://id.who.int/icd/release/11/2024-01/mms/1524522975"
  ],
  "browserUrl": "https://icd.who.int/browse/2024-01/mms/en#976309888",
  "code": "BC65.5",
  "source": "http://id.who.int/icd/entity/976309888",
  "classKind": "category",
  "title": {
    "@language": "en",
    "@value": "Catecholaminergic polymorphic ventricular tachycardia"
  },
  "definition": {
    "@language": "en",
    "@value": "Catecholaminergic polymorphic ventricular tachycardia (CPVT) is a severe genetic arrhythmogenic disorder of childhood characterised by adrenergically-induced ventricular tachycardia (bidirectional ventricular tachycardia and, less frequently, supraventricular tachycardia and atrial fibrillation) manifesting as syncope and sudden death."
  },
  "relatedEntitiesInMaternalChapter": [
    "http://id.who.int/icd/entity/1380872553"
  ],
  "indexTerm": [
    {
      "label": {
        "@language": "en",
        "@value": "Catecholaminergic polymorphic ventricular tachycardia"
      }
    },
    {
      "label": {
        "@language": "en",
        "@value": "Catecholaminergic polymorphic ventricular tachycardia due to RYR2 mutation"
      },
      "foundationReference": "http://id.who.int/icd/entity/1080233943"
    },
    {
      "label": {
        "@language": "en",
        "@value": "Catecholaminergic polymorphic ventricular tachycardia due to Calsequestrin mutation"
      },
      "foundationReference": "http://id.who.int/icd/entity/1594892019"
    }
  ]
}